We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Results 1 to 1 of 1
Most popular |Most recent

Is the Second Circuit off base in its off-label ruling?

USA - December 12 2012 While the recent Second Circuit holding in US v. Caronia may be interpreted by some as a significant decision impacting off-label promotion of prescription drugs, it may well be premature for manufacturers to modify compliance policies prohibiting off-label promotion based solely on Caronia....

Shashank Upadhye.